NIDA Health Disparities–Specific Funding Opportunities
About NIDA
- 2010 Strategic Plan
- Organization
- Offices
- Office of the NIDA Director (OD)
- Director's Page
- AIDS Research Program (ARP)
- International Program (IP)
- Intramural Research Program (IRP)
- Special Populations Office (SPO)
- Related Funding Opportunities
- NIDA SPO Research Programs
- Research Training Opportunities
- African American Researchers and Scholars Work Group (AARSWG)
- Asian American Pacific Islander Researchers and Scholars Workgroup (AAPI)
- National Hispanic Science Network
- American Indian/Alaska Native Researchers and Scholars Workgroup (AIANRSWG)
- American Indian/Alaska Native (AI/AN) Coordinating Committee
- Staff Listing
- LPC Staff
- SPO/Lead Program Coordinating (LPC) Task Force
- FAQs About: Research Supplements to Promote Diversity in Health-Related Research (Diversity Supplements)
- Instructions to Principal Investigators Applying for Research Supplements to Promote Diversity in Health-Related Research
- NIDA Consortium on Diversity Affairs
- Health Disparities
- Women & Sex/Gender Differences Research Program
- Office of Management (OM)
- Office of Extramural Affairs (OEA)
- Office of Science Policy and Communications (OSPC)
- Office of the NIDA Director (OD)
- CCTN
- Divisions
- Workgroups, Interest Groups and Consortia
- Offices
- Director's Page
- Legislative Activities
- Advisory Boards & Groups
- Employment Opportunities
- Donating to NIDA
- Contact Us
- Other Resources
Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)
PAR-09-011 (http://grants.nih.gov/grants/guide/pa-files/PAR-09-011.html)
The purpose of this ongoing program is to increase the drug-abuse and addiction-research capacity of institutions that historically and/or currently serve students from diverse and disadvantaged backgrounds. Grants will be provided to foster the research-career development of a highly diverse cadre of students, faculty and staff who are underrepresented in drug-abuse research. All capacity development and research activities must address scientific areas related to the mission and priorities of the National Institute on Drug Abuse.
HIV/AIDS, Drug Use, and Vulnerable Populations in the U.S.
PA-09-236 (R01) (http://grants.nih.gov/grants/guide/pa-files/PA-09-236.html)
PA-09-237 (R21) (http://grants.nih.gov/grants/guide/pa-files/PA-09-237.html)
This Funding Opportunity Announcement (FOA), issued by the National institute on Drug Abuse and the National Institute of Nursing Research, National Institutes of Health, encourages Research Project Grant (R01) applications to identify the role(s) that drug abuse plays in fueling the HIV/AIDS epidemic in vulnerable groups (racial/ethnic minorities, men who have sex with men, youth) in the United States, to develop effective interventions to prevent new infections, to improve the health and well-being of those living with HIV/AIDS. It is essential to understand the factors (biological, behavioral, psychosocial, environmental, institutional, etc.) responsible for the profoundly disproportionate burden of HIV/AIDS among vulnerable groups. This FOA will support studies to 1) understand the contribution of drug abuse (both injection and non-injection) to the acquisition and/or transmission of HIV; 2) study disease progression and disease outcomes; 3) develop and/or improve prevention and treatment interventions; and 4) address organizational, structural, and/or community-level factors including social, drug-using, and sexual networks.
Featured Publication
Drugs, Brains, and Behavior - The Science of Addiction
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.